Dare Bioscience Inc (DARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 27,402 | 14,345 | 16,882 | 11,181 | 631 |
| Operating Income | -27,402 | -14,345 | -16,882 | -11,181 | -631 |
| Interest Expense | 0 | 0 | 0 | 0 | 42 |
| Other Income | 2 | 81 | 144 | -323 | 0 |
| Pre-tax Income | -27,401 | -14,264 | -16,739 | -11,503 | -673 |
| Net Income Continuous | -27,401 | -14,264 | -16,739 | -11,503 | -673 |
| Net Income | $-27,401 | $-14,264 | $-16,739 | $-11,503 | $-673 |
| EPS Basic Total Ops | -10.92 | -11.64 | -18.85 | -42.74 | -9.72 |
| EPS Basic Continuous Ops | -10.93 | -10.99 | -18.72 | -42.73 | -9.67 |
| EPS Diluted Total Ops | -10.92 | -11.64 | -18.85 | -42.74 | -9.72 |
| EPS Diluted Continuous Ops | -10.93 | -10.99 | -18.72 | -42.73 | -9.67 |
| EPS Diluted Before Non-Recurring Items | -10.92 | -11.65 | N/A | N/A | N/A |
| EBITDA(a) | $-27,359 | $-14,334 | $-11,692 | $-3,690 | $-631 |